eShop
English
In today's rapidly evolving biopharmaceutical landscape, single-use system(SUS) has become indispensable—valued for its efficiency, flexibility, and cost-effectiveness. Yet none of these benefits matter without one thing: sterility. Sterility is the foundation of pharmaceutical manufacturing. For SUS that directly contacts the product, sterility assurance is absolutely critical. In this article, we examine how sterility assurance for SUS is achieved—from both perspectives of regulation and single-use product manufacturing.
Regulations Priority: The Gold Standard for Sterility
Regulations form the cornerstone of drug safety, defining the non-negotiable boundaries for the aseptic use of SUS. Major global regulatory authorities—including the FDA, EMA, and NMPA—along with PIC/S (Pharmaceutical Inspection Co-operation Scheme), have all issued clear requirements governing this area.
Key Regulatory Guidelines
EU GMP Annex 1, Manufacture of Sterile Medicinal Products, sets the gold standard for the industry. At its core is Quality Risk Management (QRM), which requires manufacturers to thoroughly assess and control contamination risks across the entire production process. This mandate extends specifically to the management of SUS.
Supplier Audits & Qualification
Regulatory authorities mandate that pharmaceutical companies conduct thorough audits of SUS suppliers to verify a robust Quality Management System (QMS). This includes evaluating the supplier's production environment, sterilization processes, testing capabilities, and change control.
Validation Requirements for Key Elements
Sterilization Process Validation Suppliers must provide comprehensive validation reports for their sterilization processes (e.g., gamma irradiation or ethylene oxide), demonstrating the effectiveness and reliability of the chosen method.
Integrity Testing For critical components such as filters, pre-use and post-use integrity testing is required to confirm that the barrier function remains intact throughout the process.
Extractables and Leachables (E&L) Studies Evaluate substances that may be released from single-use materials upon contact with the products, ensuring they do not compromise drug safety or efficacy.
EU GMP Annex 1
- 8.133 Sterilisation processes for SUS should be validated and shown to have no adverse impact on system performance.
- 8.134 Assessment of suppliers of disposable systems including sterilisation is critical to the selection and use of these systems. For sterile SUS,verification of sterility assurance should be performed as part of the supplier qualification and evidence of sterilisation of each unit should be checked on receipt.
In summary, regulations establish an overarching framework in which pharmaceutical companies and suppliers share the responsibility for sterility assurance. This means that every step must be documented and fully traceable.
Source Control: Sterility Built Into Every Single-Use Product
The sterility assurance of SUS begins right from the start of manufacturing, because the supplier's process is the first and most critical barrier—ensuring the product is born sterile before it ever leaves the factory.
Clean Production Environment
The assembly and packaging of single-use products are critical steps that must be performed in ISO-classified cleanrooms to eliminate microbial contamination at the source. Cobetter operates multiple ISO Class 7 and ISO Class 8 production workshops, supporting the manufacturing of single-use products for both up- and downstream biopharmaceutical processes. For even higher-stakes applications, Cobetter also maintains several ISO Class 5 production workshops, delivering the stringent cleanliness required to safeguard the final barrier in pharmaceutical manufacturing.
Strict Material Control
Cobetter chooses high-performance polymers—such as polyethylene and polypropylene—that comply with USP Class VI or equivalent biocompatibility requirements. Every incoming material then undergoes rigorous inspection before being approved for use.
Comprehensive Quality Control
Before single-use products leave the factory, inspections must be conducted on appearance, seal strength, bioburden, integrity, and packaging, to prevent damage that could compromise sterility during shipping or use. Cobetter has established a complete set of quality standard documentation to govern product quality. For instance, every product undergoes 100% integrity testing, and sterility testing is performed in accordance with the related regulations.
Core Sterilization Technology
Gamma irradiation is the most widely adopted method for sterilizing single-use systems. It uses gamma rays from Cobalt-60, which offer high penetration, thorough sterilization, and leave no residues, making it ideal for sealed packaging. Precise dose mapping is required throughout the process to confirm that every part of the product receives an effective sterilization dose. Cobetter follows EN ISO 11137-1:2015 for gamma irradiation sterilization. This involves selecting representatives from each product family, covering all materials, types, and suppliers, to prepare a "worst-case" bag (Octopus Bag), which is used for validation in irradiation dose and dose distribution , followed by confirmatory sterility testing. In addition, product packaging and shipping validation is conducted in accordance with ISTA-3A to ensure the integrity and safety of products during transportation.
In production control, Cobetter validates sterility assurance through two key measures: 1. Periodic Dose Audit: Following ISO 11137, a dose audit is performed quarterly using a octopus bag. This continuously monitors the product's bioburden and effectiveness of the irradiation dose. 2. Batch Sterility Testing: For each batch, a representative QC bag is selected and verified for sterility after irradiation.
① Octopus Bag Single-use bag products vary in specification, so their components may differ. Representatives are chosen from each product family according to ISO 11137-2:2013, which specifies selection criteria based on bioburden count and microbial types present. It encompasses all materials, types, and accessories from various suppliers used by the single-use manufacturer.
② Ethylene Oxide (EO) Sterilization EO sterilization is ideal for components with complex geometries or those sensitive to irradiation. After the sterilization cycle, a thorough aeration step is required to reduce residual EO below the safe limit.
Fail-Safe Packaging
SUS is typically packaged in double sterile bags. This design not only facilitates material decontamination but also provides physical protection during transport and storage. Cobetter tailors packaging to the application: Two-layer packaging for up- and downstream use. Three-layer packaging for filling bags, which require multiple unpacking steps. Validated film packaging(with supporting documentation) for materials entering Grade B areas via VHP fumigation, ensuring the fumigation process does not compromise the single-use products.
Cobetter Topene™ Test Results of Cobetter Topene™ RB Membrane
Join Forces, Guard Sterility
The sterility assurance of SUS is far from an isolated task limited to a single step. It is a systematic effort spanning the entire value chain, from regulation and manufacturing to real-world production. This demands close collaboration among three key players: regulators who provide scientific guidance, suppliers who deliver manufacturing excellence, and pharmaceutical companies who enforce rigorous implementation. As single-use systems grow more complex and integrated, sterility requirements will only intensify. Only by weaving sterility into every step can we build an unbreachable fortress, protecting the purity and safety of every drop of the drug, and advancing the cause of human health.
